Healthcare device

DE202022003139U1Active Publication Date: 2025-02-27TAIWAN OASIS TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
DE202022003139
Authority / Receiving Office
DE · DE
Patent Type
Utility models
Current Assignee / Owner
Filing Date
2022-11-29
Publication Date
2025-02-27
Estimated Expiration
2032-11-30

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

Healthcare device, featuring: a low-frequency wave transmitter (2); and a cone (4) having a cone apex (40), a cone base (41) and a cone body (42), wherein the two ends of the cone body (42) are each connected to the cone apex (40) and the cone base (41), wherein the low frequency wave transmitter (2) is connected to the cone base (41), and wherein the low frequency wave transmitter (2) can emit a low frequency wave (W) of a predetermined frequency.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The invention relates to a healthcare device and a healthcare method, in particular to a healthcare device and a healthcare method by which low-frequency waves can be transmitted to the human body for maintaining and promoting health.

[0002] Currently known health care methods used by physiotherapists include scraping, cupping, acupuncture, massage, and others. Although they can play a role in maintaining and promoting health, they also have shortcomings. For example, scraping can damage the skin and increase the risk of infection. The effect of cupping is similar to that of scraping, but the use of suction cups requires skin contact, so the cleanliness and hygiene of the suction cups is a concern. Acupuncture uses needles that penetrate the corresponding acupuncture points on the human body, so there is an invasive risk. Massage, although non-invasive, requires a person to relax the patient's muscles.

[0003] To improve the above-mentioned acupuncture therapy method, a microwave acupuncture device is known, which non-invasively irradiates acupuncture points on the human body. The microwave oscillator used in the microwave acupuncture device has an oscillation frequency of up to 1000-2000 megahertz (MHz), which can easily cause damage due to excessive radiation (energy). In fact, when using the microwave acupuncture device, it is also necessary to find the corresponding acupuncture points on the human body for treatment. However, ordinary people are not experts in traditional Chinese medicine and cannot accurately identify each acupuncture point, so the microwave acupuncture device is not actually a healthcare device that can be widely used.

[0004] Therefore, it is a trend in the industry to develop a healthcare device and procedure that is easy to use, can accurately identify usage positions, is non-invasive and contactless, and has no risk of injury from excessive energy.

[0005] The present invention is primarily based on the recognition that the major tissues and organs of the human body (referring to organisms, not artificial tissues or organs) have natural vibration frequencies, such as 8 to 12 Hz for the head, 4 to 6 Hz for the thoracic cavity, 5 Hz for the heart, 6 to 9 Hz for the thoracic cavity, 1.2 Hz for the blood flow frequency, and 1.8 Hz for bone tissue. When a certain part of the human body is in the low-frequency wave field of 0 to 20 Hz, such as bass waves or infrasound waves, also called ultrasonic waves or ultrasonic waves above 20 kHz, and when the sound pressure level [sound pressure level, unit: dB] reaches a certain threshold, the elastic wall of the outer layer of the tissue and organ corresponding to that part first enters the vibration state. Then, the vibration is transmitted to the interior of the tissue and organ.Resonance occurs especially when the frequency of the bass wave is synchronized with the aforementioned natural vibration frequency of the tissues and organs. In this case, the tissues and organs receive the greatest stimulation at this time. When the resonance caused by the bass wave affects the tissues and organs, it also affects the cellular structures of the tissues and organs, such as the mitochondria of the cells. Mitochondria are the main sites for oxidative phosphorylation and the synthesis of adenosine triphosphate (ATP) in cells, thus providing chemical energy for cellular activities. Therefore, they are called the "powerhouses of the cell."

[0006] ATP enters the membrane potential of the cell membrane (membrane potential, transmembrane potential, or membrane voltage). The cell membrane is a thin film composed of a phospholipid bilayer (lipid bilayer or phospholipid bilayer). The cell membranes of almost all cellular organisms consist primarily of phospholipid bilayers. The interior of the phospholipid bilayer is filled with dielectrics, so that the cell membrane formed by the phospholipid bilayer is electrically equivalent to a capacitor. The structure of the cell membrane includes not only the phospholipid bilayer but also proteins, some of which act as ion channels, allowing ions (such as positively charged sodium ions Na+ and potassium ions K+) to be transported across the cell membrane. This phenomenon is physically understandable.This means that the cell membrane acting as a capacitor is a leakage capacitor, with the leakage current (ion transport) flowing through the capacitor.

[0007] In addition, the resonance effect exerted on the mitochondria by the above-mentioned deep waves will also affect the binding state of some enzymes, such as ATPase, at the cell membrane and the activity of the enzyme. ATPase is an enzyme that can break down ATP to generate energy and can activate Na+ and K+. Therefore, it is also called Na + -K + -ATPase or Na + -K + -pump). The Na + -K + -pump can regulate the concentration of sodium ions and potassium ions inside and outside the cell membrane. This means that the membrane potential of the cell membrane is determined by the Na + -K +-pump adaptable. For example, the return of the membrane potential of the cell membrane from the action potential to the resting potential occurs. Initially, the cell membrane is at the resting potential. If the cell membrane is properly stimulated in the resting potential state, an action potential is generated, which normally goes through the following phases sequentially: polarization, depolarization, repolarization, and overpolarization. Especially during the overpolarization phase, the action potential is lower than the resting potential. At this time, the Na + -K +The action potential pump causes the membrane potential of the cell membrane to return from the action potential to the resting membrane potential during the overpolarization phase. Therefore, it is understandable that long-term exposure to stimuli (such as stress), long-term human inflammation, or long-term deficiency of ATP and / or ATPase will cause cells to remain in the overpolarization phase for a long time, with the membrane potential of the cell membrane lower than the resting potential.

[0008] Based on the above-mentioned understanding that the cell membrane is electrically equivalent to a capacitor (or a battery), the membrane potential of the cell membrane is equivalent to the battery's voltage. The action potential is lower than the resting potential during the above-mentioned overpolarization phase. The action potential of the cell membrane in the overpolarization phase can be understood as the residual power (voltage) after the battery is depleted (after use). The resting potential can then be understood as the initial power (voltage) that is either not dissipated or recharged. According to statistics, there are an average of 37.2 trillion cells in the human body, thus an average of 37.2 trillion "batteries" in the human body. It can be understood that when the body is chronically stressed or inflamed, the cells are correspondingly chronically hyperpolarized and thus in a state of "battery depletion."As a result, cells cannot perform or maintain their proper functions. The tissues and organs of the human body also appear sick or fatigued. At this time, when a low-frequency wave of a certain intensity and / or frequency acts on cells, the energy of the wave can be converted into thermal energy, biochemical energy, and bioelectrical energy, thereby increasing the activity of ATPase. At the same time, ATPase can cause the membrane potential of the cell membrane to return from the action potential to the resting potential during the overpolarization phase. This causes the aforementioned "battery," corresponding to human cells, to return from the state of "battery depletion" during the aforementioned overpolarization phase to the initial charge (voltage) or full charge.In other words, low-frequency waves can "recharge" cells in the hyperpolarization phase, so that the use of low-frequency waves to act on tissues and organs can repair damaged tissues, and normal functions can be restored under the stimulation of low-frequency waves. There is an example of the relationship between low-frequency waves and living organisms: For example, the frequency of the Schumann resonance in the extremely low frequency (ELF) low-frequency wave is 7.83 Hz, which is exactly the same frequency as that of the hippocampus of the mammalian brain. In particular, the alpha and theta waves of the human brain are also close to 8 Hz. Therefore, the U.S. National Aeronautics and Space Administration (NASA) installed a Schumann wave generator in the manned space capsule to maintain the physical and mental health of astronauts in space.For the increase of ATPase activity by low frequency waves, reference can be made to "Effects of low frequency magnetic fields on Na,K-ATPase activity", M. Blank, L. Soo, V. Papstein, Bioelectrochemistry and Bioenergetics 38 (1995) 267- 273". The use of 0-70 Hz low frequency waves (magnetic waves) can increase the activity of Na. + -K + -ATPase by 5-10%. In other words, low-frequency waves can activate cells and "charge" cells in the hyperpolarization phase. Therefore, low-frequency waves can be used in the "cell activation technique." It should be noted here that low-frequency waves can also include electromagnetic waves such as electric waves, magnetic waves, light waves, or bass waves.

[0009] According to traditional Chinese medicine theory, the human navel is the Shenque acupuncture point, where the Ren, Du, Dai, and Chong pulses pass through. Therefore, when the Shenque acupuncture point is stimulated, the entire body can be adjusted by connecting the internal organs through the meridians. In addition, according to Western medicine theory, the navel is the thinnest part of the epidermal cuticle in the human abdomen, and there is no fatty tissue below the navel, so its barrier function is the weakest. In addition, the skin of the navel also has a rich venous network and inferior abdominal artery branches in addition to the microcirculation blood vessels of the general skin. Therefore, as long as a certain effect or change is exerted on the blood in the microcirculation blood vessels of the umbilical skin, this effect or change can be brought into the human bloodstream.Furthermore, the position of the human navel is easy to identify and does not vary depending on the person's height, weight, and thinness. Using the navel as the corresponding position where the healthcare device emits the low-frequency wave is beneficial for the user to accurately identify the usage position.

[0010] According to the invention, it was also recognized that a low-frequency wave transmitter capable of generating low-frequency waves (e.g., low-frequency electromagnetic waves, low-frequency magnetic waves, or low-frequency sound waves) can be used to emit low-frequency waves toward the navel without coming into contact with it. This non-invasive and contactless method can achieve effects similar to those of acupuncture, thus enabling innovative, gentle, and effective health promotion. Preferably, the bass wave transmitter capable of generating the bass wave is not in contact with the navel, so that the bass wave transmitter transmits the bass wave toward the navel to achieve an effect similar to acupuncture. This allows a non-invasive, contactless health care effect to be achieved.In particular, the bass waves, low-frequency sound waves, and low-frequency sound waves referred to in the present invention have the same meaning. When the low-frequency wave is directly used as a component of the healthcare device, the problem of excessive energy risk caused by the high-frequency microwave oscillator can be avoided. At the same time, the adverse effects of electric waves or magnetic waves on some people with special constitutions can also be avoided.

[0011] Bass waves can achieve effects similar to acupuncture. In addition, acupuncture's effect on the immune system is that it can increase the levels of interferon-gamma (γ-IFN) and neuropeptide beta-endorphin, which can activate natural killer cells (NK cells). Natural killer cells also secrete cytokines, which can therefore regulate the inflammatory response. NK cells are lymphocytes with large granules in the cytoplasm and are therefore considered immune cells. They develop from lymphoid stem cells of the bone marrow and are distributed primarily in the peripheral blood (including blood in microcirculatory blood vessels) and the spleen, but also in small quantities in lymph nodes and other tissues.

[0012] As mentioned above, the navel is the thinnest part of the epidermal cuticle in the human abdomen, and there is no fatty tissue below the navel, so its barrier function is the weakest. In addition to the microcirculation blood vessels of the general skin, the navel skin also has a rich venous network and inferior abdominal artery branches. Therefore, as long as a certain effect or change is exerted on the blood in the microcirculation blood vessels of the umbilical skin, this effect or change can be introduced into the human blood circulation system. Therefore, when the bass wave is emitted toward the navel, it triggers an acupuncture-like effect, so that the levels of γ-IFN and β-endorphins in the blood in the microcirculation blood vessels of the umbilical skin increase, activating NK cells, B cells (B cells, B lymphocytes), and active T cells (or active T lymphocytes).Because NK cells, B cells, and active T cells secrete cytokines, they can regulate inflammation or secrete antibodies. When the bass wave transmitter is used to emit bass waves toward the navel, the Na can be stimulated. + -K +The ATPase activity of activated T cells in the blood vessels of the umbilical microcirculation is increased. This can increase the activity of activated T cells. In other words, when the bass wave transmitter is used to emit low-frequency waves toward the navel, the activated T cells with low activity can be "recharged" to restore their activity, so that the activated T cells that have been "recharged" can be verified. Therefore, as long as the changes in the content of NK cells, B cells, or activated T cells in the blood are detected, the effectiveness of the healthcare device according to the invention can be verified. Of course, the ability of NK cell lines to kill cancer cell lines (K562) can also be utilized.For example, the ability can be measured in samples cultured in a mixture of NK cell to target cell ratio (Effector to Target Cell Ratio, E / T ratio), and the results can be compared to verify the feasibility of the healthcare device / healthcare method of the invention.

[0013] According to the invention, there is provided a healthcare method in which a low frequency wave transmitter is arranged in front of a navel of a user and forms a predetermined distance from the navel at a predetermined position, the low frequency wave transmitter emitting a low frequency wave of a predetermined frequency toward the navel.

[0014] According to the invention, a healthcare device is provided which is arranged in front of a navel of a user and forms a predetermined distance from the navel at a predetermined position, the healthcare device comprising at least one low-frequency wave transmitter.

[0015] According to the invention, a healthcare method is provided, in which a low-frequency wave transmitter is arranged in front of a user's navel and forms a predetermined distance from the navel at a predetermined position, the low-frequency wave transmitter emitting a low-frequency wave of a predetermined frequency toward the navel, the healthcare device comprising at least the following: a low-frequency wave transmitter; a cylinder provided with a cylinder surface, a cylinder bottom surface and a cylinder body, wherein the two ends of the cylinder body are respectively connected to the cylinder surface and the cylinder bottom surface; and a cone having a cone apex, a cone bottom surface, and a cone body, wherein the two ends of the cone body are respectively connected to the cone apex and the cone bottom surface, wherein the cylinder surface and the cone bottom surface are respectively connected to each other, and wherein the low-frequency wave transmitter is connected to the cylinder bottom surface.

[0016] According to the invention, the predetermined position is located on a virtual floor surface of a virtual cone with the navel as the virtual apex, wherein the predetermined distance is in the range of 5 to 8 cm. The predetermined position is located in the center of the virtual floor surface. The virtual cone is conical, wherein the predetermined position is located in the circular center of the circular, virtual floor surface, and wherein the predetermined distance is the distance between the circular center and the navel. The apex of the cone is arranged at the predetermined position.

[0017] According to the invention, an upright rod is attached to the cone apex, facing away from the cone base. The longitudinal direction of the rod coincides with a normal line passing through the center of the cone base and faces the navel. The rod apex of the rod is located at the predetermined position.

[0018] According to the invention, a healthcare device is provided comprising: a low-frequency wave transmitter; a cylinder provided with a cylinder surface, a cylinder bottom surface and a cylinder body, wherein the two ends of the cylinder body are respectively connected to the cylinder surface and the cylinder bottom surface; and a cone having a cone apex, a cone bottom surface, and a cone body, both ends of which are respectively connected to the cone apex and the cone bottom surface, wherein the cylinder surface and the cone bottom surface are respectively connected to each other, and wherein the low-frequency wave transmitter is connected to the cylinder bottom surface, and wherein the low-frequency wave transmitter can radiate a low-frequency wave of a predetermined frequency.

[0019] According to the invention, there is further provided a healthcare device comprising: a low-frequency wave transmitter; and a cone having a cone apex, a cone bottom surface, and a cone body, wherein both ends of the cone body are respectively connected to the cone apex and the cone bottom surface, wherein the low-frequency wave transmitter is connected to the cone bottom surface, and wherein the low-frequency wave transmitter radiates a low-frequency wave of a predetermined frequency.

[0020] According to the invention, the predetermined frequency is in the range of 1.27 to 1.81 Hz.

[0021] According to the invention, the predetermined frequency is 1.45 Hz.

[0022] According to the invention, the cone is a one-piece wooden cone.

[0023] According to the invention, there is further provided a healthcare device comprising a low-frequency wave transmitter arranged in front of a navel of a user and forming a predetermined distance from the navel at a predetermined position, the healthcare device radiating a low-frequency wave of a predetermined frequency toward the navel.

[0024] The healthcare device and method proposed by the applicant of the present invention provide non-invasive and contactless healthcare while ensuring comfortable operation and accurate identification of the use position. Furthermore, there is no risk of injury due to excessive energy application.

[0025] The invention and its embodiments are explained in more detail below with reference to the drawing. The drawing shows: Fig.1 is a schematic representation of the implementation of the healthcare method according to the invention; Fig. 2 shows a schematic structural representation of a healthcare device according to the invention when carrying out the healthcare method according to the invention; Fig. 3 is a perspective structural view of the healthcare device according to the invention; Fig. 4 is a perspective structural view of the healthcare device according to the invention with a pipeline; Fig. 5 is a perspective structural view of the healthcare device according to the invention with an upright rod; Fig. 6 is a perspective structural view of the healthcare device according to the invention mounted on a storage bracket; and Fig.7 is a perspective structural view of the healthcare device according to the present invention, the low frequency wave transmitter of which is mounted on the cone bottom surface of the cone.

[0026] The present invention will be described in detail below using a specific embodiment. It should be noted, however, that components of the present invention mentioned in this embodiment are not described precisely in terms of their scale, dimensions, variables, and displacement paths, but are only shown schematically, with similar components always being designated by the same numbers.

[0027] In Fig.1 shows a healthcare method according to the present invention. A low-frequency wave W of a predetermined frequency is radiated from a low-frequency wave transmitter 2 at a predetermined position P in front of a navel 11 of a user 1 toward the navel 11, the navel 11 being separated from the predetermined position P by a predetermined distance D. The aforementioned "in front" refers to the front of the human body and is contrasted with "behind" which refers to the back of the human body. The predetermined position P is located on a virtual bottom surface S2 of a virtual cone S having the navel 11 as the virtual apex S1, such that the predetermined distance D is not greater than 8 cm, the predetermined distance D is not less than 5 cm, or the predetermined distance D is in the range of 5 to 8 cm.Preferably, the predetermined position P is located in the center of the virtual floor surface S2. For example, the virtual cone S is conical, with the predetermined position P located at the center of the circular, virtual floor surface S2. Furthermore, the predetermined distance D is the distance between the center of the circle and the navel 11, which is between 5 and 8 cm.

[0028] The low-frequency wave transmitter 2 is preferably a bass wave transducer so that the low-frequency wave W can be a bass wave. Structurally, the bass wave transducer includes a power source 21 and a vibrating element 22, wherein the vibrating element 22 is electrically connected to the power source 21. The vibrating element 22 is a disc-shaped piezoelectric ceramic transducer made of a piezoelectric material polarized in the thickness direction. The power source 21 supplies power to the vibrating element 22 so that the vibrating element 22 vibrates in the thickness direction to generate the bass wave of the predetermined frequency, wherein the predetermined frequency is not higher than 1.81 Hz, or the predetermined frequency is not lower than 1.27 Hz, or the predetermined frequency is between 1.27 and 1.81 Hz. Preferably, the predetermined frequency is 1.45 Hz.

[0029] In other words, the present invention also provides a healthcare device arranged at a predetermined position P in front of a navel 11 of a user 1 and forming a predetermined distance D with the navel 11, the healthcare device comprising at least one low-frequency wave transmitter (2). <Erkennungsverfahren und -wirkung>

[0030] I. The above-mentioned healthcare procedure was performed on subjects A1 and A2, with a predetermined distance D of 5 cm, a predetermined frequency of 1.45 Hz, and a bass wave as the low-frequency wave. Subject A1 was 74 years old, male; subject A2 was 72 years old, female. Before performing the above-mentioned healthcare procedure, blood samples were taken from subject A1 and subject A2 and sent to the medical laboratory for immunological testing to check the percentage of activated T cells. On the 19th day after performing the above-mentioned healthcare procedure for 2 hours, a blood sample was taken again from subject A1 and sent to the medical laboratory for immunological testing. On the 42nd day after performing the above-mentioned healthcare procedure for 2 hours, the same procedure was performed again for subject A2.Blood samples were sent to the medical laboratory for immunological testing, where the percentage of activated T cells was also examined. The results are recorded in Table 1 below. Table 1 Person A1 Person A2 1 2 3 1 2 3 Content of activated T cells 6.2% 12.8% 206.5% 5.3% 7.9% 149% 1: before implementation 2: after implementation 3: Rate of change = After implementation / Before implementation

[0031] From Table 1, it can be seen that the activated T cell content in person A1 before performing the above-mentioned healthcare method is 6.2%, and after performing the above-mentioned healthcare method, the activated T cell content increases to 12.8%, with a change rate of 206.5%. That is, the activated T cell content increases by 106.5%. Furthermore, in person A2, the activated T cell content before performing the above-mentioned healthcare method is 5.3%, and after performing the above-mentioned healthcare method, the activated T cell content increases to 7.9%, with a change rate of 149%. That is, the activated T cell content increases by 49%. Therefore, the proliferation of activated T cells can be promoted by the healthcare method of the present invention.As long as a single application of the above-mentioned healthcare method lasts for 2 hours, the level of activated T cells can be increased. The 49% increase was maintained even after 42 days. Clearly, the healthcare method according to the invention is very effective and can maintain long-term health benefits.

[0032] II. The above-mentioned healthcare procedure was performed on 14 individuals, with a predetermined distance D of 5 cm, a predetermined frequency of 1.45 Hz, and a bass wave as the low-frequency wave. Before performing the above-mentioned healthcare procedure, a blood sample was taken from each of the 14 individuals and sent to the medical laboratory for immunological testing to check the percentage of B cells (CD19+). On the 19th day after performing the above-mentioned healthcare procedure for 2 hours, a blood sample was taken again from each of the 14 individuals and sent to the medical laboratory for immunological testing to also check the percentage of B cells (CD19+). The average results of the 14 individuals are shown in Table 2 below. Table 2 1 2 3 B cell content 12.2% 13.6% 111.4% 1: before implementation 2: after implementation 3: Rate of change = After implementation / Before implementation

[0033] From Table 2, it can be seen that the average B cell count of the 14 subjects before performing the aforementioned healthcare procedure was 12.2%, and the average B cell count after performing the aforementioned healthcare procedure increased to 13.6%, with a change rate of 111.4%. That is, the B cell count increased by 11.4%. Therefore, the healthcare procedure of the present invention can promote B cell proliferation, and the B cell count can be increased as long as the procedure is performed for 2 hours. Obviously, the healthcare procedure of the present invention has an effective healthcare effect.

[0034] III. The above-mentioned healthcare procedure was performed on subject B1 and subject B2, with the predetermined distance D being 5 cm, the predetermined frequency being 1.45 Hz, and the low-frequency wave being a bass wave. Before performing the above-mentioned healthcare procedure, blood samples were collected from subject B1 and subject B2. On the 19th day after performing the above-mentioned healthcare procedure for 2 hours, a respective blood sample was collected again from subject B1 and subject B2. The NK cells in the blood and the cancer cell line (K562) were mixed and co-cultured at a ratio of 6.25:1 (effector:target) for the two blood collection samples. Afterward, the death status of cancer cell lines could be analyzed. This could determine the percentage of the ability of NK cells to kill cancer cell lines. For this, refer to TW I439275. The average results are shown in Table 3 below. Table 3 Person B1 Person B2 1 2 3 1 2 3 Proportion of cancer cell lines killed by NK cells 24.3% 33.6% 138.3% 5.5% 7.2% 131% 1: before implementation 2: after implementation 3: Rate of change = After implementation / Before implementation

[0035] Table 3 shows that the percentage of NK cell killing ability (K562) in person B1 was 24.3% before the aforementioned healthcare procedures, and increased to 33.6% after the aforementioned healthcare procedures. This means the rate of change is 138.3%. In other words, the killing ability increased by 38.3%. In person B2, the percentage of NK cell killing ability (K562) in person B1 was 5.5% before the aforementioned healthcare procedures, and increased to 7.2% after the aforementioned healthcare procedures. This means the rate of change is 131%. In other words, the killing ability increased by 31%. Therefore, the ability of NK cells to kill cancer cell lines (K562) can be increased by the healthcare method of the present invention.Apparently, the healthcare method of the invention is highly effective and can maintain the effectiveness of healthcare in the long term.

[0036] With reference to Fig. 2 and Fig.3, the present invention also provides a healthcare device 100 that can be used to perform the aforementioned healthcare method. The healthcare device 100 according to the invention comprises the aforementioned low-frequency wave transmitter 2, a cylinder 3, and a cone 4. The cylinder 3 is preferably designed as a round cylinder. The cylinder 3 has a cylinder surface 31, a cylinder bottom surface 32, and a cylinder body 33, the two ends of which are respectively connected to the cylinder surface 31 and the cylinder bottom surface 32. The cone 4 has a cone apex 40, a cone bottom surface 41, and a cone body 42, the two ends of which are respectively connected to the cone apex 40 and the cone bottom surface 41. The cylinder surface 31 is correspondingly connected to the cone bottom surface 41, for example, by welding or screwing. Preferably, the cylinder 3 and the cone 4 are metal cylinders and metal cones, respectively.Particularly preferably, the cylinder 3 and the cone 4 are formed integrally. In other words, the cylinder surface 31, the cylinder body 33, the cone body 42, and the cone tip 40 are formed integrally.

[0037] The low-frequency wave transmitter 2 is connected to the cylinder bottom surface 32. Preferably, the low-frequency wave transmitter 2 is directly connected to the cylinder bottom surface 32. For example, the low-frequency wave transmitter 2 is welded or screwed to the cylinder bottom surface 32. Therefore, when the energy source 21 is activated, the vibration element 22 generates the low-frequency wave W of the predetermined frequency [see Fig.1]. Then, the low-frequency wave W is transmitted to the cylinder bottom surface 32 and further transmitted through the cylinder body 33 to the cone bottom surface 41 and the cone apex 40 in succession. The cone 4 is tapered from the wider cone bottom surface 41 to the narrower cone apex 40, so that the energy of the low-frequency wave W is more concentrated when it is transmitted to the cone apex 40. When the low-frequency wave W reaches the cone apex 40, the energy of the low-frequency wave W is concentrated to the maximum, and the low-frequency wave W is radiated from the cone apex 40 toward the navel 11. Since the cone apex 40 is formed as a peak, the low-frequency wave W can satisfy a condition similar to the "peak discharge" in electricity, so that the energy of the low-frequency wave W is concentrated at the cone apex 40 and radiated toward the navel 11.It should be noted that the cone tip 40 is located at the predetermined position P.

[0038] In another embodiment according to Fig. 4, the low-frequency wave transmitter 2 is connected to the cylinder bottom surface 32 by a conduit 5. The low-frequency wave W is transmitted from the low-frequency wave transmitter 2 to the cylinder bottom surface 32 through the conduit 5, then, as described above, transmitted to the cone apex 40 and radiated toward the navel 11. The conduit 5 allows the energy source 21 and / or the vibration element 22 of the low-frequency wave transmitter 2 to be kept away from the human body, thereby preventing interference with an electronic device implanted in the human body.

[0039] In a further embodiment according to Fig.5, an upright rod 401 is attached to the cone tip 40, facing away from the cone bottom surface 41. The rod 401 is preferably designed as a metal rod, metal wire, or wire. The longitudinal direction of the rod 401 coincides with a normal line N of the cone bottom surface 41, passing through the center C of the cone bottom surface 41 and facing the navel 11. In this way, the energy of the low-frequency wave W can be directed more strongly, so that the energy is concentrated on a rod tip 402 of the rod 401 and released toward the navel 11. It should be noted that the rod tip 402 is located at the predetermined position P.

[0040] In yet another embodiment according to Fig.6, the healthcare device 100 is attached to a support bracket 200. A user 1 lies on a platform (not shown), with the support bracket 200 positioned on the platform and the healthcare device 100 positioned above the user's navel. This allows the user to rest properly even during healthcare.

[0041] According to another embodiment in Fig.7, the healthcare device 100 may include the above-mentioned low-frequency wave transmitter 2 and the cone 4, but without the cylinder 3. The low-frequency wave transmitter 2 is attached to and connected to the cone bottom surface 41. Preferably, the low-frequency wave transmitter 2 is directly connected to the cone bottom surface 41. For example, the low-frequency wave transmitter 2 is glued, welded, or screwed to the cone bottom surface 41. Therefore, when the power source 21 is turned on, the vibration element 22 generates the low-frequency wave W of the predetermined frequency [see Fig.1]. Then, the low-frequency wave W is transmitted to the cone bottom surface 41 and the cone tip 40 of the cone 4. The cone 4 may be conically shaped from the wider cone bottom surface 41 to the narrower cone tip 40, so that the energy of the low-frequency wave W is more concentrated when it is transmitted to the cone tip 40. Preferably, the cone 4 is a one-piece wooden cone.

[0042] The invention thus relates to a healthcare device comprising a low-frequency wave transmitter (2) and a cone (4), wherein the low-frequency wave transmitter (2) is connected to the bottom surface of the cone (4). The low-frequency wave transmitter (2) can emit a low-frequency wave (W) of the predetermined frequency. The predetermined frequency is in the range of 1.27 to 1.81 Hz. The healthcare device according to the invention can increase the content of activated T cells and B cells in the blood and improve the ability of NK cells to kill cancer cell lines (K562), achieving the effect of convenient operation and accurate identification of the application site. Furthermore, the healthcare device according to the invention is non-invasive, contactless, and causes no harm due to excessive energy. The foregoing description illustrates the embodiments of the invention and is not intended to limit the claims. All equivalent changes and modifications that can be made by one skilled in the art in accordance with the description and drawings of the invention are within the scope of the present invention. List of reference symbols 1 user 11 Belly button 2 low-frequency wave transmitters 21 Energy source 22 Vibration element 200 storage brackets 100 healthcare devices 3 cylinders 31 Cylinder surface 32 Cylinder bottom surface 33 cylinder bodies 4 cones 40 cone tip 401 sticks 402 rod tip 41 Cone bottom surface 42 conical bodies 5 Pipeline C Middle D predetermined distance N Normal line P predetermined position S virtual cone S1 virtual tip S2 virtual floor area W Low frequency wave QUOTES CONTAINED IN THE DESCRIPTION

[0000] This list of documents submitted by the applicant was generated automatically and is included solely for the convenience of the reader. This list is not part of the German patent or utility model application. The DPMA assumes no liability for any errors or omissions. Cited non-patent literature

[0000] Effects of low frequency magnetic fields on Na,K-ATPase activity”, M. Blank, L. Soo, V. Papstein, Bioelectrochemistry and Bioenergetics 38 (1995) 267- 273

[0008]

Claims

[1] Healthcare device, comprising: a low-frequency wave transmitter (2); and a cone (4) having a cone tip (40), a cone bottom surface (41) and a cone body (42), wherein the two ends of the cone body (42) are respectively connected to the cone tip (40) and the cone bottom surface (41), wherein the low-frequency wave transmitter (2) is connected to the cone bottom surface (41), and wherein the low-frequency wave transmitter (2) can radiate a low-frequency wave (W) of a predetermined frequency. [2] Healthcare device according to claim 1, characterized by that the predetermined frequency is in the range of 1.27 to 1.81 Hz. [3] Healthcare device according to claim 2, characterized by that the predetermined frequency is 1.45 Hz. [4] Healthcare device according to claim 3, characterized bythat the low-frequency wave transmitter (2) is designed as a bass wave converter, wherein the low-frequency wave (W) is a bass wave. [5] Healthcare device according to claim 4, characterized by that the bass wave converter has an energy source (21) and a vibration element (22), wherein the vibration element (22) is electrically connected to the energy source (21). [6] Healthcare device according to claim 5, characterized by that the vibration element (22) is a disc-shaped piezoelectric ceramic transducer. [7] Healthcare device according to claim 6, characterized in that the cone (4) is a one-piece wooden cone. [8] A healthcare device according to claim 7, wherein the low frequency wave transmitter (2) is fixed to the bottom surface of the cone (4) by means of a screw. [9] A healthcare device according to claim 3, wherein the low frequency wave transmitter (2) is selected from a group comprising a low frequency electromagnetic wave emitter and a low frequency magnetic wave emitter. [10] Healthcare device according to claim 9, characterized in that the cone (4) is a one-piece wooden cone. [11] A healthcare device arranged in front of a navel (11) of a user (1) and forming a predetermined distance (D) from the navel (11) at a predetermined position (P), the healthcare device comprising at least one low-frequency wave transmitter (2).